Nicolas Leupin

Insider Reports History

Location
Root, Switzerland
Signature
Steven Robbins, as attorney in fact for Leupin, Nicolas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicolas Leupin:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd Chief Medical Officer Ordinary Shares 105,108 $1,911,915 $18.19 04 Mar 2025 Direct
NovoCure Ltd Chief Medical Officer Stock Options (Right to buy) 81,499 $1,482,467 $18.19 04 Mar 2025 Direct

Insider Reports Filed by Nicolas Leupin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCR NovoCure Ltd 04 Mar 2025 2 +$2,482,462 4 Chief Medical Officer 06 Mar 2025, 16:42
NVCR NovoCure Ltd 27 Feb 2025 2 -$19,844 4/A Chief Medical Officer 03 Mar 2025, 21:26
NVCR NovoCure Ltd 27 Feb 2024 2 +$2,107,557 4 Chief Medical Officer 29 Feb 2024, 16:33
NVCR NovoCure Ltd 02 Jan 2024 0 $0 3 Chief Medical Officer 11 Jan 2024, 17:15